Autoimmune Diseases / 2012 / Article / Tab 3

Clinical Study

Improved Metabolic Control in Diabetes, HSP60, and Proinflammatory Mediators

Table 3

Summary of serum cytokine values reported from recent studies.

ReferenceIL-1β pg/mLIL-6 pg/mLIL-8 pg/mLIL-10 pg/mLIL-12 pg/mLTNFα pg/mLDiabetes duration (Years)Nationality

Mol et al. 1997 [24]0.8161.1910 ± 7*Dutch
Adachi et al. 2004 [25]2.4UnknownJapanese
Doganay et al. 2002 [26]<0.05<0.058.36.6 Turkish
Lee et al. 2008 [27]0.941.475.110.773.95 Korean
Mishra et al. 20111 [28]6.1211838.6newly diagnosedIndian
Mishra et al. 20112 [28]9.5514750.8newly diagnosedIndian
McGee et al. 2011 [29]7.0316.91 yr. MinimumBritish
Park et al. 2011 [30]1.785.1Korean
Hu et al. 20093 [31]21.80.065UnknownChinese
Hu et al. 20094 [31]38.50.111UnknownChinese
Ozturk et al. 2009 [32]4.01104.88.13 Turkish
Current Study012.05104.63.781.410.83 Italian

Values ± SEM except where indicated. Mishra et al. and Hu et al. both divided their diabetic populations into 2 groups: one by CRP and the other by presence or absence of evidence of atherosclerosis. Last row is baseline values for current study. *Standard deviation; 1CRP< 3, 2CRP > 3; 3no evidence of atherosclerosis; 4evidence of atherosclerosis (increased carotid IMT).

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.